Novo Nordisk, Eli Lilly
Took Ozempic or Mounjaro? Lawsuit Targets Novo Nordisk Over GI Injuries
A large-scale drug lawsuit against Novo Nordisk claims Ozempic and Mounjaro caused serious gastrointestinal harm. Users who took these GLP-1 drugs may be affected by the case.
Key facts
- Claim deadline
- No deadline listed
- Potential payment
- Payment varies
- Proof listed
- May be required
- Status
- Upcoming
Plain-language overview
Who may qualify?
Eligibility depends on the dates, products, locations, and other terms listed for this claim. Review any criteria below and the official terms before deciding whether it may apply to you.
Case overview
What this settlement is about
A major lawsuit is unfolding against the makers of GLP-1 receptor agonist drugs, with plaintiffs claiming that medications like Ozempic and Mounjaro led to serious gastrointestinal injuries. The alleged harms include gastroparesis, intestinal blockages, and severe, persistent vomiting. According to the lawsuit, the drug makers knew of these risks but failed to adequately warn patients and misrepresented how safe the medications actually were.
